135 related articles for article (PubMed ID: 11493221)
1. Paraneoplastic neurological syndromes - patients' cohort profile in the Czech Republic.
Stourac P; Kadanka Z; Palyza V
Acta Neurol Scand; 2001 Aug; 104(2):72-7. PubMed ID: 11493221
[TBL] [Abstract][Full Text] [Related]
2. Antigen-specific oligoclonal bands in cerebrospinal fluid and serum from patients with anti-amphiphysin- and anti-CV2/CRMP5 associated paraneoplastic neurological syndromes.
Stich O; Rauer S
Eur J Neurol; 2007 Jun; 14(6):650-3. PubMed ID: 17539943
[TBL] [Abstract][Full Text] [Related]
3. Disturbance in the serum IgG subclass distribution in patients with anti-Hu positive paraneoplastic neurological syndromes.
Blaes F; Klotz M; Funke D; Strittmatter M; Kraus J; Kaps M
Eur J Neurol; 2002 Jul; 9(4):369-72. PubMed ID: 12099920
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid study in paraneoplastic syndromes.
Psimaras D; Carpentier AF; Rossi C;
J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):42-5. PubMed ID: 19324868
[TBL] [Abstract][Full Text] [Related]
5. Enzyme linked immunosorbent assay using recombinant HuD-autoantigen for serodiagnosis of paraneoplastic neurological syndromes.
Rauer S; Kaiser R
Acta Neurol Scand; 2001 Apr; 103(4):248-54. PubMed ID: 11328197
[TBL] [Abstract][Full Text] [Related]
6. Antibody types and IgG subclasses in paraneoplastic neurological syndromes.
Greenlee JE; Boyden JW; Pingree M; Brashear HR; Clawson SA; Keeney PM
J Neurol Sci; 2001 Mar; 184(2):131-7. PubMed ID: 11239946
[TBL] [Abstract][Full Text] [Related]
7. Microtubule-associated protein 1B: Novel paraneoplastic biomarker.
Gadoth A; Kryzer TJ; Fryer J; McKeon A; Lennon VA; Pittock SJ
Ann Neurol; 2017 Feb; 81(2):266-277. PubMed ID: 28074593
[TBL] [Abstract][Full Text] [Related]
8. Imbalances in circulating lymphocyte subsets in Hu antibody associated paraneoplastic neurological syndromes.
de Beukelaar JW; Sillevis Smitt PA; Hop WC; Kraan J; Hooijkaas H; Verjans GM; Gratama JW
Eur J Neurol; 2007 Dec; 14(12):1383-91. PubMed ID: 18028190
[TBL] [Abstract][Full Text] [Related]
9. Imbalance in circulating T lymphocyte subsets contributes to Hu antibody-associated paraneoplastic neurological syndromes.
Zhang L; Qian W; Chen Q; Yin L; Li B; Wang H
Cell Immunol; 2014 Aug; 290(2):245-50. PubMed ID: 25173445
[TBL] [Abstract][Full Text] [Related]
10. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
[TBL] [Abstract][Full Text] [Related]
12. Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations.
Ruiz-García R; Martínez-Hernández E; García-Ormaechea M; Español-Rego M; Sabater L; Querol L; Illa I; Dalmau J; Graus F
Front Immunol; 2019; 10():769. PubMed ID: 31031763
[TBL] [Abstract][Full Text] [Related]
13. Neurological paraneoplastic syndromes in lung cancer patients.
Stefens-Stawna P; Piorunek T; Gabryel-Batura H; Kozubski W; Michalak S
Adv Exp Med Biol; 2013; 756():333-9. PubMed ID: 22836651
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of anti-SOX1 reactivity in various neurological disorders.
Berger B; Dersch R; Ruthardt E; Rasiah C; Rauer S; Stich O
J Neurol Sci; 2016 Oct; 369():342-346. PubMed ID: 27653921
[TBL] [Abstract][Full Text] [Related]
15. Specific antibody index in cerebrospinal fluid from patients with central and peripheral paraneoplastic neurological syndromes.
Stich O; Jarius S; Kleer B; Rasiah C; Voltz R; Rauer S
J Neuroimmunol; 2007 Feb; 183(1-2):220-4. PubMed ID: 17229470
[TBL] [Abstract][Full Text] [Related]
16. [Pathogenesis of paraneoplastic neurological syndromes].
Tanaka K
Brain Nerve; 2010 Apr; 62(4):309-18. PubMed ID: 20420170
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes.
Vatankulu B; Yilmaz Aksoy S; Asa S; Sager S; Sayman HB; Halac M; Sonmezoglu K
Rev Esp Med Nucl Imagen Mol; 2016; 35(1):17-21. PubMed ID: 26260889
[TBL] [Abstract][Full Text] [Related]
18. [Intrathecal synthesis of the anti-Hu antibody in patients with paraneoplastic encephalomyelitis or sensory neuronopathy].
Qian W; Lu Y; Chen Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Apr; 22(2):196-8. PubMed ID: 12903528
[TBL] [Abstract][Full Text] [Related]
19. A paraneoplastic syndrome misdiagnosed as ALS: What are the red flags? A case report and review of the literature.
Tolkovsky A; Kipervasser S; Fainmesser Y; Alcalay Y; Gadoth A
J Neuroimmunol; 2021 Sep; 358():577635. PubMed ID: 34217018
[TBL] [Abstract][Full Text] [Related]
20. Qualitative evidence of Ri specific IgG-synthesis in the cerebrospinal fluid from patients with paraneoplastic neurological syndromes.
Jarius S; Stich O; Rasiah C; Voltz R; Rauer S
J Neurol Sci; 2008 May; 268(1-2):65-8. PubMed ID: 18096187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
